Boston Scientific Corp

자세한 내용은 Boston Scientific Corp 회사

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

회사 정보

종목 코드 BSX

회사 이름Boston Scientific Corp

상장일May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

직원 수53000

유형Stock Index Future

회계 연도 종료May 19

주소300 Boston Scientific Way

도시MARLBOROUGH

증권 거래소BSE Ltd

국가United States of America

우편 번호01752-1234

전화15086834000

웹사이트https://www.bostonscientific.com/en-US/Home.html

종목 코드 BSX

상장일May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

기타

1.27B

27.32%

지역별USD

이름

수익

비율

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

사업별

지역별

사업별USD

이름

수익

비율

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

기타

1.27B

27.32%

주식 보유 통계

마지막 업데이트: Sat, Aug 16

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

기타

72.06%

주주

비율

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

6.71%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.40%

PRIMECAP Management Company

2.34%

기타

72.06%

주주 유형

주주

비율

Investment Advisor

51.16%

Investment Advisor/Hedge Fund

29.03%

Hedge Fund

4.14%

Pension Fund

2.73%

Research Firm

2.53%

Bank and Trust

2.05%

Sovereign Wealth Fund

1.54%

Family Office

0.23%

Private Equity

0.21%

기타

6.38%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

106.170USD

Boston Scientific Corp

106.170

개요

회사

금융